Hydrochloric Acid

Hydrochloric Acid

SCHEMBL9549754

Cl.NC(N)N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115745450-B Method for enhancing adhesion and interfacial water stability of solid waste of building and application thereof 河南工业大学 2024-02-13 CN claimed
CN-116005860-A Sound insulation type aluminum plate curtain wall 江苏德铝佳新材料有限公司 2023-04-25 CN claimed
CN-115745450-A Method for enhancing adhesion of building solid waste and interfacial water stability and application 河南工业大学 2023-03-07 CN claimed
CN-113314748-B Preparation method of enhanced proton exchange membrane based on surface modified polymer framework 安徽中能元隽氢能科技股份有限公司 2022-09-02 CN claimed
CN-114868767-A High-temperature-resistant composite antibacterial agent and preparation method thereof 沈藉兵 2022-08-09 CN claimed
CN-108191971-B Preparation method of recombinant human metallothionein III alpha fragment pure product 汇海(苏州)生物技术有限公司 2022-02-22 CN claimed
US-4030977-A Method for purification of physiologically active substance using enzyme-enzyme inhibitor system ONO PHARMACEUTICAL CO., LTD. (JA) 1977-06-21 US claimed
CN-122068240-A Composite diaphragm, preparation method thereof and secondary battery 玉溪恩捷新材料有限公司 2026-05-19 CN disclosed
EP-4720094-A1 MUTATED FRAGMENT OF VZV GLYCOPROTEIN E Suzhou Abogen Biosciences Co., Ltd. (CN) 2026-04-08 EP disclosed
EP-4335509-B1 NOVEL GLUTAMINYL CYCLASE INHIBITORS AND THE USE THEREOF IN TREATMENT OF VARIOUS DISEASES VALENTA INTELLEKT LTD (RU) 2026-03-11 EP disclosed
EP-3632433-B1 NOVEL GLUTAMINYL CYCLASE INHIBITORS AND THE USE THEREOF IN TREATMENT OF VARIOUS DISEASES NEBOLSIN VLADIMIR EVGENIEVICH (RU) 2025-12-24 EP disclosed
US-12397051-B2 Vaccine for use against coronavirus and variants thereof Globe Biotech Limited (BD) 2025-08-26 US disclosed
CN-115820578-B Mutant composition, fusion enzyme and preparation method of collagen tripeptide 深圳瑞德林生物技术有限公司 2025-06-10 CN disclosed
EP-0055588-B1 ANALGESIC AND ANTI-INFLAMMATORY AGENTS SANKYO COMPANY LIMITED (JP) 1983-10-26 EP disclosed
US-4400534-A PROPIONIC ACID COMPOUNDS SANKYO COMPANY, LIMITED (JP) 1983-08-23 US disclosed
EP-0007787-B1 METHOD AND REAGENT FOR THE QUANTITATIVE DETERMINATION OF HYDROGEN PEROXIDE KYOWA HAKKO KOGYO CO., LTD (JP) 1982-11-03 EP disclosed
EP-0055588-A1 Analgesic and anti-inflammatory agents SANKYO COMPANY LIMITED (JP) 1982-07-07 EP disclosed
US-4260679-A Method and reagent for the quantitative determination of hydrogen peroxide and precursors thereof KYOWA HAKKO KOGYO CO., LTD. (JP) 1981-04-07 US disclosed
EP-0007787-A1 Method and reagent for the quantitative determination of hydrogen peroxide KYOWA HAKKO KOGYO CO., LTD (JP) 1980-02-06 EP disclosed
US-4030977-A Method for purification of physiologically active substance using enzyme-enzyme inhibitor system ONO PHARMACEUTICAL CO., LTD. (JA) 1977-06-21 US disclosed